Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Molecular Pharmaceutics|August 7, 2014
[(18)F](2S,4S)-4-(3-Fluoropropyl)glutamine as a tumor imaging agentZehui Wu, Zhihao Zha, Genxun Li, et al.
Journal of Medicinal Chemistry|December 7, 2007
2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agentsAjit K Parhi, Julie L Wang, Shunichi Oya, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|October 28, 2008
Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomographyPeter J H Scott, Brian G Hockley, Hank F Kung, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2004
Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP miceMei-Ping Kung, Catherine Hou, Zhi-Ping Zhuang, et al.
Neuroscience Bulletin|September 25, 2013
Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133)Yajing Liu, Feng Yue, Rongping Tang, et al.
Nuclear Medicine and Biology|December 24, 2019
[<sup>68</sup>Ga]Ga-HBED-CC-DiAsp: A new renal function imaging agentShengyu Shi, Lifang Zhang, Zehui Wu, et al.
Bioconjugate Chemistry|January 18, 2007
Fluoro-pegylated (FPEG) imaging agents targeting Abeta aggregatesKarin A Stephenson, Rajesh Chandra, Zhi-Ping Zhuang, et al.
Nuclear Medicine and Biology|May 8, 2010
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's diseaseJulie L Wang, Shunichi Oya, Ajit K Parhi, et al.
Nuclear Medicine and Biology|July 23, 2019
VMAT2 imaging agent, D6-[<sup>18</sup>F]FP-(+)-DTBZ: Improved radiosynthesis, purification by solid-phase extraction and characterizationRuiyue Zhao, Zhihao Zha, Xinyue Yao, et al.
Bioorganic & Medicinal Chemistry|February 1, 2020
Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancerXinyue Yao, Zhihao Zha, Karl Ploessl, et al.
Pageof 19